1例原发性肝癌合并2型糖尿病行射频消融术治疗后并发肝脓肿的药学监护

吴逸梅; 盛月红; 刘毅; 谢从景; 葛继芸; 黄玉凤

doi:10.3969/j.issn.1006-0111.2019.04.016

1例原发性肝癌合并2型糖尿病行射频消融术治疗后并发肝脓肿的药学监护

doi: 10.3969/j.issn.1006-0111.2019.04.016

海军军医大学附属东方肝胆外科医院, 上海, 200438

Pharmacological monitoring in a case of primary hepatocellular carcinoma with type 2 diabetes mellitus followed by hepatic abscess after radiofrequency ablation

Eastern Hepatobiliary Surgery Hospital Affiliated to Naval Medical University, Shanghai 200438, China

摘要: 目的探讨原发性肝癌合并2型糖尿病行射频消融术治疗后并发肝脓肿的药学监护。方法临床药师、护士与医生配合，对1例原发性肝癌合并2型糖尿病行射频消融术治疗后并发肝脓肿患者实施药学监护。通过对肝肾功能监护调整药物、按血培养结果调整抗生素、严密监测血压血糖等措施，在分析疾病、提供用药方案、监护药物不良反应及相互作用等方面提供药学服务。结果在治疗过程中，感染病情得到控制，肝肾功能恢复正常，未出现药物不良反应，患者31 d后肝脓肿治愈出院。结论实施药学监护对原发性肝癌合并2型糖尿病行射频消融术治疗后并发肝脓肿患者的抗菌治疗起到了积极作用。
- 原发性肝癌 /
- 射频消融术 /
- 药学监护 /
- 肝脓肿
Abstract: Objective To investigate the pharmacological monitoring in a hepatic abscess patient after radiofrequency ablation for primary hepatocellular carcinoma with type 2 diabetes mellitus. Methods The patient's liver and kidney function were monitored to tailor the medication regimen.The antibiotic therapy was adjusted based on the blood culture results.Blood pressure and blood sugar were also closely monitored.Pharmaceutical care is provided based on the diseases progress,the optimization of drug regimens,the monitoring of adverse drug reactions and interactions. Results In the course of treatment,no adverse drug reactions occurred.The infection was under control and the liver and kidney function returned to normal.The patient was recovered and discharged after 31 days of hospital stay. Conclusion Pharmaceutical care plays an active role in the antibiotic treatment for the seriously infected patients.
- primary liver cancer /
- radiofrequency ablation /
- pharmaceutical care /
- liver abscess

[1]	PARK S I,LEE D Y,WON J Y,et al.Extrahepatic collateral supply of hepatocellular carcinoma by the intercostal arteries[J].J Vasc Interv Radiol,2003,14(4):461-468.
[2]	SUH S H,WON J Y,LEE D Y,et al.Chemoembolization of the left inferior phrenic artery in patients with hepatocellular carcinoma:radiographic findings and clinical outcome[J].J Vasc Interv Radiol,2005,16(12):1741-1745.
[3]	CHEN M S,LI J Q,ZHENG Y,et al.A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma[J].Ann Surg,2006,243(3):32l-328.
[4]	CHEN M H,YANG W,YAN K,et al.Large liver tumors:protocol for radiofrequency ablation and its clinical application in 110 patients:mathematic model,overlapping mode,and electrode placement process[J].Radiology,2004,232(1):260-271.
[5]	高文,陈敏华,严昆,等.射频消融治疗非手术适应证小肝癌疗效分析[J].中国医学影像技术,2007,23(2):254-257.
[6]	徐瑞琴,冯喜英,汪海燕,等.患者应用头孢类药物不良反应与其过敏史相关性的调查[J].临床医学,2009,29(4):119-120.
[7]	周远华,方海顺,苏广海,等.注射用脂溶性维生素(I)与两种常用输液的配伍稳定性考察[J].中国药房,2013,16(4):573-576.
[8]	MELONI M F,GOLDBERG S N,MOSER V,et al.Colonic perforation and abscess following radiofrequency ablation treatment of hepatoma[J].Eur J Ultrasound,2002,15(1-2):73-76.
[9]	SHIBATA T,YAMAMOTO Y,YAMAMOTO N,et al.Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors:incidence and risk factors[J].J Vasc Interv Radiol,2003,14(12):1535-1542.
[10]	姚健楠,刘福全,岳振东,等.射频消融治疗原发性肝癌围手术期安全性分析[J].中国肿瘤临床,2012(7):404-407.
[11]	晏建军,严以群,周飞国,等.糖尿病合并肝脓肿的外科诊治[J].肝胆外科杂志,2002,10(2):96-97.
[12]	王健,闫子光,佟小强,等.肝肿瘤射频消融术后感染性并发症的处理[J].中国介入影像与治疗学,2016,13(3):155-158.
[13]	宗登伟,郭晨阳,黎海亮,等.肝肿瘤CT引导经皮射频消融重要并发症临床分析[J].当代医学,2013(27):8-10.
[14]	侯继野,姜杨,董延龙,等.肝脏肿瘤患者射频消融术后感染相关并发症及其临床分析[J].中华医院感染学杂志,2016,26(22):5163-5165.
[15]	SHI S,XIA W,GUO H,et al.Unique characteristics of pyogenic liver abscesses of biliary origin[J].Surgery,2016:S0039606015009514.
[16]	高文,陈敏华,严昆,等.射频消融治疗非手术适应证小肝癌疗效分析[J].中国医学影像技术,2007,23(2):254-257.
[17]	张列祥,郑晶,陆海,等.天晴甘美治疗重型颅脑损伤后肝功能损害的临床研究[J].重庆医学,2015(28).
[18]	程时,丁海勤.谷胱甘肽及其抗氧化作用今日谈[J].生理科学进展,2002,33(1):85-90.
[19]	王能,钱国军,沈强,等.经皮肝穿刺射频治疗肝恶性肿瘤的严重并发症分析[J].中华肝胆外科杂志,2011,17(3):186-188.
[20]	白浪,徐珊玲,王晓辉,等.Ⅱ型糖尿病合并肝脓肿32例临床分析[J].寄生虫病与感染性疾病,2005,3(3):116-117.
[21]	张燕荣,甄健存,等.依据《药品不良反应信息通报》探讨避免药品不良反应发生的措施[J].中国医院药学杂志,2015,35(2):156-160.

[1]	朱鑫宇, 白浩然, 赵娜萍, 戚大川, 卫立辛, 张黎. 基于网络药理学探明八宝丹治疗原发性肝癌的潜在机制研究 . 药学实践与服务, 2024, 42(4): 157-164. doi: 10.12206/j.issn.2097-2024.202401061
[2]	刘玉兰, 刘梅, 鲁毅, 毕慧, 许桂丽. 1例急性心肌梗死合并三尖瓣修补术患者的抗栓治疗及药学监护 . 药学实践与服务, 2023, 41(12): 760-762. doi: 10.12206/j.issn.2097-2024.202204122
[3]	罗晶晶, 吴新安, 薛刚, 解正东, 叶剑波, 戎成婷. 临床药师参与1例足部损伤患者术后MRSA感染治疗的药学监护 . 药学实践与服务, 2022, 40(3): 286-288. doi: 10.12206/j.issn.1006-0111.202102004
[4]	张芸婷, 付慧, 李冬洁, 黄芳, 沈甫明. 临床药师参与1例胃癌术后腹腔感染合并蜂窝组织炎患者的药学监护 . 药学实践与服务, 2022, 40(6): 580-582. doi: 10.12206/j.issn.2097-2024.202107101
[5]	骆锦前, 陆松伟, 田泾, 虞慧华. 1例2型糖尿病伴骨质疏松患者的药学监护 . 药学实践与服务, 2022, 40(5): 473-476. doi: 10.12206/j.issn.2097-2024.202110024
[6]	卢进, 赵新才, 陈蓓蓉, 赵赟, 王婧, 霍炎. 药师对1例转移性乳腺癌术后伴癌痛患者的药学监护 . 药学实践与服务, 2021, 39(4): 359-361. doi: 10.12206/j.issn.1006-0111.202101028
[7]	刘婷, 曹忠强, 湛敏, 张洲, 吴越, 李学娟, 陈泽彬. 1例儿童细菌性脑膜炎的治疗分析与药学监护 . 药学实践与服务, 2021, 39(2): 174-177. doi: 10.12206/j.issn.1006-0111.202012022
[8]	胡云英, 冯瑾, 贾耀, 葛继芸, 鲍蕾蕾, 黄玉凤. 1例鹦鹉热衣原体重症肺炎并发药物性肝损伤患者的治疗及药学监护 . 药学实践与服务, 2021, 39(6): 552-556. doi: 10.12206/j.issn.1006-0111.202103043
[9]	韦春兰, 李文渊. 1例甲巯咪唑致全血细胞减少及肝损伤患者的药学监护 . 药学实践与服务, 2021, 39(1): 86-89. doi: 10.12206/j.issn.1006-0111.202004025
[10]	管文婕, 陈慧慧, 汪涛, 张晨晨, 陈延杰, 朱捷. 冠状动脉介入术后发生肝素诱导的血小板减少症抗栓治疗的药学监护 . 药学实践与服务, 2019, 37(4): 370-374. doi: 10.3969/j.issn.1006-0111.2019.04.017
[11]	葛海沂, 丁楠. 1例Ⅱ型血小板减少症的药学监护并文献复习 . 药学实践与服务, 2019, 37(3): 279-282. doi: 10.3969/j.issn.1006-0111.2019.03.018
[12]	范梦瑶, 宋琳, 田泾. 临床药师参与1例肝衰竭患者糖皮质激素治疗的分析与药学监护 . 药学实践与服务, 2018, 36(5): 464-467. doi: 10.3969/j.issn.1006-0111.2018.05.019
[13]	曹琴, 李昱柳. 1例支气管扩张合并糖尿病、痛风患者的药学监护 . 药学实践与服务, 2017, 35(2): 171-173. doi: 10.3969/j.issn.1006-0111.2017.02.019
[14]	沈绍清, 任浩洋. 1例粒细胞缺乏伴发热患者抗感染治疗的药学监护 . 药学实践与服务, 2016, 34(4): 363-365. doi: 10.3969/j.issn.1006-0111.2016.04.021
[15]	吉小丽, 戴映, 宋洪涛. 1例肾移植术后并发带状疱疹患者的药学监护体会 . 药学实践与服务, 2015, 33(1): 68-71. doi: 10.3969/j.issn.1006-0111.2015.01.019
[16]	刘丽娜, 刘晓东, 肇丽梅. 1例糖尿病合并侵袭性肺曲霉菌感染患者的药学监护 . 药学实践与服务, 2014, 32(5): 389-392. doi: 10.3969/j.issn.1006-0111.2014.05.022
[17]	战旗, 顾大伟, 徐丽丽, 陈俊, 范立青, 龚纯贵. 原发性肝癌患者介入治疗感染及抗菌药物应用分析 . 药学实践与服务, 2010, 28(2): 142-145.
[18]	谢华, 谢景文, 王荣, 贾正平, 徐丽婷, 马骏. 药学监护在癫痫疾病中应用的体会 . 药学实践与服务, 2007, (3): 166-168.
[19]	佟雪菲, 陈盛新, 蒯丽萍, 忻伟明. 药学人力资源现状分析与开发对策 . 药学实践与服务, 2007, (2): 114-116.
[20]	王守春, 韩丽萍, 姚小莉, 骆科. 肾移植术后的药学监护 . 药学实践与服务, 2004, (6): 365-367.

点击查看大图

计量

文章访问数: 2751
HTML全文浏览量: 384
PDF下载量: 590
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

1例原发性肝癌合并2型糖尿病行射频消融术治疗后并发肝脓肿的药学监护

doi: 10.3969/j.issn.1006-0111.2019.04.016

Pharmacological monitoring in a case of primary hepatocellular carcinoma with type 2 diabetes mellitus followed by hepatic abscess after radiofrequency ablation

计量

1例原发性肝癌合并2型糖尿病行射频消融术治疗后并发肝脓肿的药学监护

doi: 10.3969/j.issn.1006-0111.2019.04.016

海军军医大学附属东方肝胆外科医院, 上海, 200438

English Abstract

Pharmacological monitoring in a case of primary hepatocellular carcinoma with type 2 diabetes mellitus followed by hepatic abscess after radiofrequency ablation

Eastern Hepatobiliary Surgery Hospital Affiliated to Naval Medical University, Shanghai 200438, China

全文HTML

目录

留言板

1例原发性肝癌合并2型糖尿病行射频消融术治疗后并发肝脓肿的药学监护

doi: 10.3969/j.issn.1006-0111.2019.04.016

Pharmacological monitoring in a case of primary hepatocellular carcinoma with type 2 diabetes mellitus followed by hepatic abscess after radiofrequency ablation

计量

出版历程

1例原发性肝癌合并2型糖尿病行射频消融术治疗后并发肝脓肿的药学监护

doi: 10.3969/j.issn.1006-0111.2019.04.016

海军军医大学附属东方肝胆外科医院, 上海, 200438

English Abstract

Pharmacological monitoring in a case of primary hepatocellular carcinoma with type 2 diabetes mellitus followed by hepatic abscess after radiofrequency ablation

Eastern Hepatobiliary Surgery Hospital Affiliated to Naval Medical University, Shanghai 200438, China

全文HTML

目录